Helicos Genetics Patent Ruled Invalid In Illumina Row

Law360, New York (August 29, 2012, 3:15 PM EDT) -- A patent infringement crusade embarked upon by Helicos BioSciences Corp. ended on Tuesday as a Delaware federal judge found Helicos' remaining genetics analysis patent invalid, letting Illumina Inc. off the hook for allegedly incorporating it into its scanning technology.

U.S. District Judge Sue L. Robinson allowed Illumina, the last remaining defendant in the case, to exit after determining that the genetics analysis invention asserted by Helicos was not covered by the language of its patent description, granting Illumina's motion for summary judgment on invalidity.

“In sum,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.